Clinical trial NCT00256659: Hospital Outcomes: Intervention in Moderately III Patients
Official title: Hospital Outcomes: Intervention in Moderately III Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital
Keywords: Medical inpatients
Social Work
Physical therapy
Occupational therapy
Psychiatry
Early intervention
Iatrogenic complications
Lead sponsor: Weill Medical College of Cornell University
Sponsor class: OTHER
First posted: 2005-11-21
Enrollment: 444
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: To evaluate the utility of real time prognostic data (illness severity, stability and function) in the improvement of hospitalization morbidity, mortality, iatrogenic complications and length of stay.

Detailed description: To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.

This is a randomized study which will compare the current Standard of Care in hospital to EARLY assessment and referrals with respect to social work services, rehabilitation, psychiatry, and nursing. In this study, the control group will receive the hospital support services provided under current system of delivery and allocation. The intervention group will not receive any new or different services not already provided to all patients at New York Presbyterian Hospital. The difference between the 2 groups will be the uniformity of screening to identify the needs of the patient in the respective area of social services, rehabilitation, psychiatric assistance, and nursing care, and the timeliness by which the referrals for support services will be placed.

Potential interventions: (In both control and experimental group)

1. Social work: Discharge planning (homecare, visiting nursing services, skilled nursing facility placement).
2. Rehabilitation: Physical Therapy (improve ADLs-activities of daily living).
3. Psychiatry: Diagnosis and Assistance in management of Depression.
4. Nursing: Prevention of in hospital falls and decubitus ulcer formation.

Eligibility criteria: Inclusion Criteria:

1. All medical in-patients who are coded moderately ill with fair to poor function in the SIGNOUT program will be asked to participate in our study.
2. Patients who are able to provide verbal consent for their participation will be enrolled.

Exclusion Criteria:

1. Any patient not coded in the SIGNOUT system as moderately ill with fair to poor function.
2. Patients who refuses not to participate in the study.
3. Patients who are unable to give written informed consent.

Primary outcomes:
measure: To evaluate the utility of real time prognostic data and in the improvement of hospitalization morbidity, mortality, iatrogenic complications, and length of stay.
Secondary outcomes:
measure: To evaluate resource allocation and efficiency of ancillary service delivery in aggregate cost and 3 month follow up in regards to hospital readmission, living environment, and utilization of social services.
Other outcomes:
Locations:
city: New York
country: United States
facility: New York Presbyterian Hospital- Weill Medical Center
state: New York
Study officials:
affiliation: Weill Medical College of Cornell University
name: Mary E Charlson, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Weill Medical College of Cornell University
name: James Hollenberg, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Weill Medical College of Cornell University
name: Mark Pecker, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Weill Medical Center of Cornell University
name: Sona Euster, MSW
role: PRINCIPAL_INVESTIGATOR
affiliation: Weill Medical Center of Cornell University
name: Delia Gorga, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Weill Medical College of Cornell University
name: Mary Cooper, MD
role: PRINCIPAL_INVESTIGATOR
References: